Women's Health

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its MagSense targeted imaging agent.

Jan. 27, 2026 —  Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading institutions across the country, have published a new study that provides radiation oncologists with practical guidance to identify and protect female sexual organs during pelvic…

Jan. 027, 2026 — QT Imaging and Olea Medical have announced plans to collaborate.

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast tomosynthesis (DBT) dataset with paired histology outcomes.

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual tumor marker designed to provide artifact-free visibility across all major breast imaging modalities, including MRI, mammography, X-ray, CT and ultrasound.